NEW YORK (360Dx) – Genetic Signatures today said that it has received regulatory approvals in Australia and Europe for separate enteric products.

Australia's Therapeutic Goods Administration has approved the firm's Enteric Viral Detection product. Additionally, its EasyScreen Enteric Pathogen Detection Kit range received CE-IVD marking.

The company had previously secured regulatory approval for its Enteric Protozoan, Enteric Bacterial, and C. difficile detection products, it said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.